Home›Geriatric›Sarcopenia: The Muscle Loss Almost Nobody Screens For

Sarcopenia: The Muscle Loss Almost Nobody Screens For

Sarcopenia affects about 1 in 10 adults over 60 — but unlike blood pressure or cholesterol, there's no routine test most people ever get.

20 Jun 2026·2 min read·RehabGoWhere Editorial

Sarcopenia — the age-related loss of muscle mass and strength — affects roughly 1 in 10 adults over 60, and considerably more in hospital and nursing home settings. It's also rarely screened for. Unlike blood pressure or cholesterol, there's no routine check most people ever encounter, despite sarcopenia being strongly linked to falls, hospitalisation, and loss of independence.

Why It Gets Missed

Sarcopenia is often mistaken for ordinary ageing — someone getting a bit weaker, a bit slower, needing a bit more help with jars and stairs. Without a specific screening pathway, that gradual decline rarely gets flagged as a distinct, identifiable condition until it's already advanced.

Two-stat diagram: roughly 10% of adults 60+ have sarcopenia, higher in hospital and nursing home settings, versus zero routine screening tests most people ever encounter.

The Actual Screening Pathway

The European Working Group on Sarcopenia in Older People (EWGSOP2) defines a clear four-step pathway: Find, Assess, Confirm, Severity. Find uses a short questionnaire (SARC-F) or clinical suspicion to flag who needs checking. Assess measures grip strength or chair-stand performance against specific cutoffs. Confirm uses a scan (DXA) to measure actual muscle mass. Severity is graded using gait speed or similar performance tests.

There's a defined, four-step pathway for catching this early — the gap isn't in the science, it's in whether anyone runs the test.

Four-step EWGSOP2 diagram: Find (SARC-F questionnaire), Assess (grip strength/chair stand), Confirm (DXA scan), Severity (gait speed), with grip strength cutoffs noted below 27kg for men and below 16kg for women.

The Simplest Part of the Test

Grip strength is the most practical entry point — a hand dynamometer, three maximal squeezes, best of the dominant hand. The EWGSOP2 cutoffs are specific: below 27kg for men, below 16kg for women, flags probable sarcopenia and warrants further assessment. It takes under two minutes and needs no special facility.

What To Do With a Positive Screen

Resistance training is the primary evidence-based intervention — it directly targets the muscle mass and strength sarcopenia erodes, in a way that walking or general activity alone doesn't replicate. Adequate protein intake supports the training response but doesn't substitute for it.

✓Ask about a grip strength test at a routine check-up — it's rarely offered unprompted
✓Note real-world signs: difficulty opening jars, rising from low chairs, carrying groceries
✓Don't dismiss gradual weakening as "just getting older" without at least one objective check
✓Prioritise resistance training over general activity if a screen comes back positive
✓Recheck periodically — sarcopenia is progressive, and a single normal test doesn't rule out future decline

Key Takeaways

—Sarcopenia affects roughly 10% of adults over 60, far more in hospital and care settings, but has no routine screening most people encounter.
—It's easily mistaken for ordinary ageing rather than flagged as a distinct, identifiable condition.
—EWGSOP2 defines a clear four-step pathway — Find, Assess, Confirm, Severity — starting with a simple questionnaire and grip strength test.
—Grip strength cutoffs are specific and fast to check: below 27kg for men, below 16kg for women.
—Resistance training is the primary evidence-based response — general activity and protein alone aren't substitutes for it.

Disclaimer: This article is for educational purposes only and does not constitute medical advice. Always consult a registered physiotherapist or healthcare professional for advice specific to your condition.

Category

Geriatric

Healthy ageing, falls prevention, post-fracture rehab, and mobility for older adults.